Still hungry on 7.5 mg Mounjaro? Here's what's actually happening

End-of-dose hunger vs. overall insufficient suppression: they need different responses

The most useful thing to do right now is work out when the hunger hits. If it arrives mostly in the two or three days before your next weekly injection, that's an end-of-dose pattern. Tirzepatide's concentration in the blood peaks a day or two after injection and then gradually falls over the week. For some people, appetite creeps back as levels dip, not because the dose is wrong for them overall, but because the trough is lower than the peak. That's worth noting and telling your prescriber about, but it doesn't automatically mean you need a higher dose.

If the hunger is present most days, fairly evenly across the week, that's a different signal. It may mean 7.5 mg hasn't reached the threshold where tirzepatide meaningfully suppresses your appetite. The licensed schedule runs from 2.5 mg through to 15 mg, and the SURMOUNT-1 trial (which involved over 2,500 adults) showed that average weight reduction increased substantially at higher doses. Many participants saw the sharpest gains between the mid and upper doses. If you want a fuller picture of what people commonly experience, the guide to feeling hungry on 7.5 mg Mounjaro covers the most frequent patterns and what tends to drive them. It may simply mean you haven't reached your effective dose yet.

A third possibility: the appetite suppression is working, but stress, disrupted sleep or eating too quickly is overriding it. Tirzepatide slows gastric emptying and signals fullness through gut hormones, but those signals compete with cortisol, habit and distraction. Ruling out behavioural factors is worth doing before concluding the dose is insufficient. You can read about how tirzepatide works in more depth on the Mounjaro treatment overview.

What changes at 7.5 mg compared with lower doses, and why hunger might still be present

It's easy to feel frustrated here. You've moved up from 5 mg expecting a clear shift, and if the hunger hasn't changed much, that's genuinely discouraging. The 7.5 mg step is the first dose where some people notice a meaningful change in appetite; for others, that step doesn't arrive until 10 mg or 12.5 mg. Biology isn't tidy.

Several factors influence how much suppression you feel at a given dose. Body weight plays a role, a higher starting weight generally means a larger volume of distribution, so the same dose produces lower plasma concentrations. Gut motility varies between individuals, which affects how long the stomach stays full. And GLP-1 receptor sensitivity differs between people at a genetic level. None of this is your fault, and none of it means the medicine won't work for you at a higher dose.

Practically, the composition of meals matters more on tirzepatide than off it. High-protein, high-fibre meals extend the fullness signal the medicine produces. Ultra-processed foods, which digest quickly, can produce a hunger rebound even when gastric emptying is slowed. If meals are carbohydrate-heavy and low in protein, you may feel hungry sooner than the dose might otherwise allow. The pattern at 10 mg is similar, for people who move up and still find hunger persists.

What your prescriber can do, and why this decision shouldn't be made alone

The decision you're actually facing is whether to continue at 7.5 mg, titrate upward, or look more closely at lifestyle factors. That decision belongs with your prescriber, not a forum. A clinician can review your weight trajectory since starting treatment, how you're tolerating the current dose, and whether there are reasons to hold at 7.5 mg rather than move up.

Tirzepatide is a Black Triangle medicine under additional MHRA monitoring, and dose changes require clinical assessment. Increasing a dose without that review isn't safe practice. Your prescriber will also check that any hunger isn't masking something else, medication timing, hydration status or a concurrent condition can all confuse the picture. The nume FAQs cover some common questions about how the review process works.

If you're wondering what the medicine costs at different doses and how that sits within a private treatment pathway, the Mounjaro price comparison page gives honest context on UK private pricing. For now, the most useful next step is a conversation with a prescriber who can look at the whole picture. At nume, every repeat order is clinically re-reviewed by a GPhC-registered Independent Prescriber before anything changes, a real clinician reads your case, not an automated queue.

Practical steps while you wait to speak to your prescriber

A few things are genuinely worth trying before your next clinical review, all of them consistent with NHS guidance on lifestyle alongside weight-management medicines. Aim for 25–30 g of protein at each main meal, this extends satiety more than any other macronutrient, and it matters more on tirzepatide because the medicine amplifies fullness signals that protein already triggers. Eat slowly; the gut hormones that signal fullness to the brain take roughly 20 minutes to register, and eating quickly outpaces them even when gastric emptying is slowed.

Hydration is easy to overlook. Mild dehydration produces a sensation that mimics hunger, a glass of water before reaching for a snack is a low-effort test. Sleep debt raises ghrelin (a hunger hormone) and reduces leptin (the satiety hormone), so persistent poor sleep will make any appetite-suppressing medicine less effective. These aren't magic fixes, but they close the gap that a mid-range dose sometimes leaves open.

If you started at 2.5 mg and have been working up through the doses, you can compare how hunger felt at earlier doses, the 2.5 mg hunger page and the 5 mg equivalent may be useful reference points. And if the question is more about whether this dose is the right one for you overall, the treatment options overview gives broader context on how private weight-management pathways work in the UK. Speak to our prescribers if you want a same-day clinical review of where you are on your current dose, that conversation is included in every step of treatment with nume.